Edwards Lifesciences has received the US Food and Drug Administration (FDA) approval for its SAPIEN M3 mitral valve replacement system. It is said to be the first transcatheter therapy using a ...
Edwards Lifesciences has been awarded CE mark for the Sapien M3 mitral valve replacement system. The approval is for the transcatheter treatment of patients with symptomatic (moderate-to-severe or ...
Edwards’ Pascal and Abbott’s MitraClip TEER devices are cleared in the U.S. to repair the mitral valve in patients with mitral regurgitation. The condition occurs when the valve does not shut properly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results